An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases

Husseini, Jad S.; Amorim, Bárbara Juarez; Torrado‐Carvajal, Angel; Prabhu, Vinay; Groshar, David; Umutlu, Lale; Herrmann, Ken; Cañamaque, Lina García; Garzón, J.R. García; Palmer, William E.; Heidari, Pedram; Shih, Tiffany Ting-Fang; Matushita, Cristina Sebastião; Cerci, Juliano Júlio; Queiroz, Marcelo A.; Muglia, Valdair Francisco; Nogueira-Barbosa, Marcello Henrique; Borra, Ronald; Kwee, Thomas C.; Glaudemans, Andor W J M; Evangelista, Laura; Salvatore, Marco; Cuocolo, Alberto; Soricelli, Andrea; Herold, Christian; Laghi, Andréa; Mayerhoefer, Marius E.; Mahmood, Umar; Catana, Ciprian; Rosen, Bruce R.; Catalano, Onofrio A.

doi:10.1007/s00259-021-05198-2

Cited by 7 publications

(3 citation statements)

References 113 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Specific time-signal curves have also been associated with high cellularity in whole spine perfusion in MM patients, and better correlate with viable malignancy [31] (Figure 1). A new hybrid technology combining PET and MRI has the potential to detect bone and extramedullary lesions through simultaneous metabolic and anatomic information [32]. Some studies have shown that 18 F-FDG-PET / MRI has the ability to detect medullary compression and bone lesions in patients with newly diagnosed SMM and newly diagnosed MM, with a higher diagnostic performance for MRI which detected focal lesions in 30% and 22% of PET-negative examinations [33].…”

Section: Dynamic Contrast-enhanced Mrimentioning

confidence: 99%

Advanced Mri Techniques for Multiple Myeloma Detection and Management- Current Knowledge and Future Prospects

2023

IJOR

View full text Add to dashboard Cite

Multiple myeloma is a neoplastic disorder of plasma cells, characterized by bone marrow infiltration, with a high morbidity and mortality. Imaging plays an important role in diagnosis, prognosis and evaluation of treatment response. Whole-body CT remains the mainstay for screening, but MRI has emerged as the most sensitive technique for lesion detection. In this article we will review the new emerging imaging modalities and future developments concerning multiple myeloma.

show abstract

Section: Dynamic Contrast-enhanced Mrimentioning

confidence: 99%

Advanced Mri Techniques for Multiple Myeloma Detection and Management- Current Knowledge and Future Prospects

2023

IJOR

View full text Add to dashboard Cite

show abstract

“…They clarified that FDG PET/MRI was identified as a feasible diagnostic strategy for the initial staging of rectal cancer from a costeffectiveness perspective. An international expert opinion statement has shown the utility of FDG PET/MRI for imaging skeletal metastases with several advantages compared with FDG PET/CT (higher detection, better characterization of skeletal lesions, and better delineation of extra-osseous tumor spread and spinal cord compression) [8]. They concluded FDG PET/MRI should be considered for the staging of malignancies where there is a high likelihood of metastatic osseous disease based on the characteristics of the primary malignancy, high clinical suspicious and in cases where the presence of skeletal metastases will have an impact on patient management.…”

Section: Pet/mri With Fdg In Oncologymentioning

confidence: 99%

“…Some previous studies have presented the superiority of MRI to CT in characterizing bone lesions. Thus it is expected that PSMA PET/MRI might be advantageous over PET/CT as well as in evaluating local prostate tumors [8].…”

Section: Pet/mri With Psma and Fapi In Oncologymentioning

confidence: 99%

Recent topics of the clinical utility of PET/MRI in oncology and neuroscience

et al. 2022

View full text Add to dashboard Cite

Since the inline positron emission tomography (PET) / magnetic resonance imaging (MRI) system appeared in clinical, more than a decade has passed. In this article, we have reviewed recently-published articles about PET/MRI. There have been articles about staging in rectal and breast cancers by PET/MRI using fluorodeoxyglucose (FDG) with higher diagnostic performance in oncology. Assessing possible metastatic bone lesions is considered a proper target by FDG PET/MRI. Other than FDG, PET/MRI with prostate specific membrane antigen (PSMA)-targeted tracers or fibroblast activation protein inhibitor have been reported. Especially, PSMA PET/MRI has been reported to be a promising tool for determining appropriate sites in biopsy. Independent of tracers, the clinical application of artificial intelligence (AI) for images obtained by PET/MRI is one of the current topics in this field, suggesting clinical usefulness for differentiating breast lesions or grading prostate cancer. In addition, AI has been reported to be helpful for noise reduction for reconstructing images, which would be promising for reducing radiation exposure. Furthermore, PET/MRI has a clinical role in neuroscience, including localization of the epileptogenic zone. PET/MRI with new PET tracers could be useful for differentiation among neurological disorders. Clinical applications of integrated PET/MRI in various fields are expected to be reported in the future.

show abstract

A review on the added value of whole-body MRI in metastatic lobular breast cancer

et al. 2022

View full text Add to dashboard Cite

An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases

Abstract: Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Cited by 7 publications

References 113 publications

Advanced Mri Techniques for Multiple Myeloma Detection and Management- Current Knowledge and Future Prospects

Advanced Mri Techniques for Multiple Myeloma Detection and Management- Current Knowledge and Future Prospects

Recent topics of the clinical utility of PET/MRI in oncology and neuroscience

A review on the added value of whole-body MRI in metastatic lobular breast cancer

Contact Info

Product

Resources

About